{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:15Z","timestamp":1793170035491,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.drugalcdep.2016.02.042","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T03:46:45Z","timestamp":1457495205000},"page":"16-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Naloxone without the needle \u2212 systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5413-2725","authenticated-orcid":false,"given":"John","family":"Strang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmalik","family":"Alqurshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Royall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0005","series-title":"Consideration of Naloxone","author":"ACMD","year":"2012"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0010","unstructured":"Alqurshi, A., Kumar, Z., McDonald, R., Strang, J., Buanz, A., Ahmed, S., Allen, E., Cameron, P., Rickard, J., Sandhu, V., Holt, C., Stansfield, R., Taylor, D., Forbes, B., Royall, P., in press. Amorphous formulation and in vitro performance testing of instantly disintegrating buccal tablets for the emergency delivery of naloxone."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/10903120290938797","article-title":"Intranasal administration of naloxone by paramedics","volume":"6","author":"Barton","year":"2002","journal-title":"Prehosp. Emerg. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jemermed.2005.03.007","article-title":"Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting","volume":"29","author":"Barton","year":"2005","journal-title":"J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0025","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jama.2012.14205","article-title":"Prevention of fatal opioid overdose","volume":"308","author":"Beletsky","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0030","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1080\/10903120600885134","article-title":"Naloxone use in a tiered-response emergency medical services system","volume":"10","author":"Belz","year":"2006","journal-title":"Prehosp. Emerg. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0035","series-title":"Goodman & Gilman\u2019s The Pharmacological Basis of Therapeutics","year":"2010"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0040","first-page":"10","article-title":"CDC grand rounds: prescription drug overdoses \u2014 a U.S epidemic","volume":"61","author":"CDC","year":"2012","journal-title":"MMWR"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999\u20132009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0050","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1211\/jpp.58.10.0003","article-title":"Intranasal midazolam: a comparison of two delivery devices in human volunteers","volume":"58","author":"Dale","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1360-0443.2010.03140.x","article-title":"Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies","volume":"106","author":"Degenhardt","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0060","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4155\/tde.14.41","article-title":"The nasal approach to delivering treatment for brain diseases: an anatomic physiologic, and delivery technology overview","volume":"5","author":"Djupesland","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0065","doi-asserted-by":"crossref","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","article-title":"Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose","volume":"99","author":"Doe-Simkins","year":"2009","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/FTD.0b013e3181816214","article-title":"Population pharmacokinetics of intravenous intramuscular, and intranasal naloxone in human volunteers","volume":"30","author":"Dowling","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0075","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","article-title":"Opioid education and nasal naloxone rescue kits in the emergency department","volume":"16","author":"Dwyer","year":"2015","journal-title":"West. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0080","series-title":"Sterile Product Development, Advances in the Pharmaceutical Sciences (AAPS Series 6)","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-7978-9_5","article-title":"Considerations for the development of nasal dosage forms","author":"Ehrick","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0085","series-title":"Route of Administration","author":"FDA","year":"1992"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0090","series-title":"FDA Moves Quickly to Approve Easy-to-use Nasal Spray to Treat Opioid Overdose","author":"FDA","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0095","series-title":"FDA Grants Fast Track to Insys Therapeutics\u2019 Naloxone","author":"FDAnews","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0022-3565(25)29707-5","article-title":"Disposition of naloxone-7, 8-3H in normal and narcotic-dependent men","volume":"187","author":"Fishman","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0105","series-title":"Naloxone for Outpatient Use: Data Required to Support an NDA","author":"Hertz","year":"2012"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0378-5173(84)90097-8","article-title":"Nasal absorption of naloxone and buprenorphine in rats","volume":"21","author":"Hussain","year":"1984","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-5173(87)90147-5","article-title":"Buccal and oral bioavailability of naloxone and naltrexone in rats","volume":"36","author":"Hussain","year":"1987","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0120","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/A:1015958417047","article-title":"Improved buccal delivery of opioid analgesics and antagonists with bitterless prodrugs","volume":"5","author":"Hussain","year":"1988","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5694\/j.1326-5377.2005.tb06550.x","article-title":"Randomised trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose","volume":"182","author":"Kelly","year":"2005","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0130","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/j.1360-0443.2009.02724.x","article-title":"Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose","volume":"104","author":"Kerr","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","article-title":"Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers","volume":"53","author":"Knoester","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-3956(92)90014-F","article-title":"Nasal administration of naloxone for detection of opiate dependence","volume":"26","author":"Loimer","year":"1992","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0145","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/10826089409047912","article-title":"Nasal administration of naloxone is as effective as the intravenous route in opiate addicts","volume":"29","author":"Loimer","year":"1994","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0150","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/adc.60.1.38","article-title":"Rectal aminophylline in the management of apnoea of prematurity","volume":"60","author":"Lyon","year":"1985","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0155","series-title":"Buccal Midazolam (Buccolam): New Authorised Medicine for Paediatric Use\u2014care Needed when Transferring from Unlicensed Formulations","author":"MHRA","year":"2011"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0160","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/01.WNL.0000067993.60735.77","article-title":"Direct access of drugs to the human brain after intranasal drug administration?","volume":"60","author":"Merkus","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0165","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ajem.2008.12.009","article-title":"Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses","volume":"28","author":"Merlin","year":"2010","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0170","series-title":"Epilepsy \u2212 Scenario: Managing a Seizure","author":"NICE","year":"2009"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0175","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/add.13027","article-title":"Naloxone\u2014does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin\/opioid overdose","volume":"110","author":"Neale","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0180","unstructured":"ONS, 2015. Statistical Bulletin: Deaths Related to Drug Poisoning in England and Wales: 2014 Registrations. http:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/deaths\/bulletins\/deathsrelatedtodrugpoisoninginenglandandwales\/2015-09-03. (accessed on 12.11.15.)."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0185","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2013.04.070","article-title":"Controlled delivery of naltrexone by an intraoral device: in vivo study on human subjects","volume":"452","author":"Paderni","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0190","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/08897077.2013.781565","article-title":"Necrosis of the intranasal structures and soft palate as a result of heroin snorting: a case series","volume":"34","author":"Peyri\u00e8re","year":"2013","journal-title":"Subst. Abuse"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0376-8716(90)90136-3","article-title":"Effects of sublingually given naloxone in opioid-dependent human volunteers","volume":"25","author":"Preston","year":"1990","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0200","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","article-title":"Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths","volume":"33","author":"Rando","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0205","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/10903120903144866","article-title":"Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose","volume":"13","author":"Robertson","year":"2009","journal-title":"Prehosp. Emerg. Care"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5114\/aoms.2014.42584","article-title":"Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trial","volume":"10","author":"Sabzghabaee","year":"2014","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2125.1998.00781.x","article-title":"Midazolam pharmacokinetics following intravenous and buccal administration","volume":"46","author":"Schwagmeier","year":"1998","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0220","series-title":"Gray's Anatomy","author":"Standring","year":"2015"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0225","doi-asserted-by":"crossref","DOI":"10.1111\/add.13209","article-title":"Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?","author":"Strang","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0230","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/13651500802233886","article-title":"Buccal midazolam for agitation on psychiatric intensive care wards","volume":"12","author":"Taylor","year":"2008","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0235","series-title":"Opioid Overdose: Preventing and Reducing Opioid Overdose Mortality","author":"UNODC\/WHO","year":"2013"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0240","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0245","series-title":"Community Management of Opioid Overdose","author":"WHO","year":"2014"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jsat.2012.07.004","article-title":"Opioid overdose prevention with intranasal naloxone among people who take methadone","volume":"44","author":"Walley","year":"2013","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0255","doi-asserted-by":"crossref","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2016.02.042_bib0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10903127.2011.640763","article-title":"Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?","volume":"16","author":"Weber","year":"2012","journal-title":"Prehosp. Emerg. Care"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871616001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T18:02:06Z","timestamp":1748800926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871616001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":52,"alternative-id":["S0376871616001411"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.042","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Naloxone without the needle \u2212 systematic review of candidate routes for non-injectable naloxone for opioid overdose reversal","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.02.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}